We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Videos

From Sequencing to Interpretation: Bioinformatics Challenges in Next Generation Sequencing Cancer Dx content piece image
Video

From Sequencing to Interpretation: Bioinformatics Challenges in Next Generation Sequencing Cancer Dx

This lecture will use our experiences at The University of Chicago Medicine to highlight some of the common analytical, technical, and regulatory challenges that bioinformatics groups face when helping to set up oncology genomics clinical diagnostics practices.
Agilent and Breast Pathology content piece image
Video

Agilent and Breast Pathology

Ping Tang, B.Med., Ph.D., University of Rochester Medical Center, discusses her work on tackling breast cancer.
Fast PCR with AllinOneCycler & AccuPower PreMix  content piece image
Video

Fast PCR with AllinOneCycler & AccuPower PreMix

Learn more about the AllinOneCycler.
Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries  content piece image
Video

Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries

This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.
Microinjecting CRISPR: Options and key considerations for creating transgenic animal models content piece image
Video

Microinjecting CRISPR: Options and key considerations for creating transgenic animal models

In this webinar, we will present experimental approaches and real-life examples for creating transgenic animal models using CRISPR.
Multi-site LIMS Harmonization content piece image
Video

Multi-site LIMS Harmonization

Epigenetic Analysis Using Highly Validated Antibodies and Optimized ChIP Assays content piece image
Video

Epigenetic Analysis Using Highly Validated Antibodies and Optimized ChIP Assays

Protecting the Food Supply Chain from Farm to Fork content piece image
Video

Protecting the Food Supply Chain from Farm to Fork

Detection and Characterization of Nanoparticles in Food and Biological Materials content piece image
Video

Detection and Characterization of Nanoparticles in Food and Biological Materials

With the increasing use of nanotechnology in food and consumer products, there is a need for reliable detection and characterization methods for nanoparticles (NPs) in complex matrices. NPs often interact with each other or with their surroundings leading to aggregation, adhesion to surfaces or dissolution in dispersion solvents. Accurate and precise characterization of metrics such as size, shape, particle mass and number concentration therefore remains a challenging analytical task. Asymmetric flow field flow fractionation (AF4) hyphenated with inductively coupled plasma mass spectrometry (ICP-MS) is a powerful technique for the detection and characterization of inorganic NPs in complex matrices. In order to acquire accurate data the AF4 separation method and settings must be optimized for each new sample matrix and analyte NP combination. Furthermore, additional information obtained by single particle (sp) ICP-MS analysis of collected fractions or an imaging method such as transmission electron microscopy (TEM) are necessary for trouble shooting and for independent verification of results. spICP-MS as stand-alone technique is a powerful screening method for many inorganic NPs. A number of examples where AF4-ICP-MS and single particle ICP-MS were applied for the detection and characterization of NPs in food and biological matrices will be presented including: • Silver NPs in chicken meat • Silicon dioxide NPs in tomato soup • Aluminum-containing NPs in noodles • Gold NPs in cells
Beyond Genomics For Personalized Medicine content piece image
Video

Beyond Genomics For Personalized Medicine

The proteome is the most functional component encoded for in the genome. Advances in proteomic technologies allow comprehensive profiling of of signaling pathways, precise expression of therapeutic targets in tissues and cellular subcompartments, and of metabolomic features that determine likelihood of therapeutic response. Moreover the current paradigm shift in cancer therapy with dramatic and durable responses to antibody and checkpoint therapeutics that trascend tumor genomic profiles further emphasize opportunities to identify novel targets and tailor treatment based on their expression patterns. The potential for personalizing cancer treatment based on proteomic and metabolomic profiles will be presented for epithelial type tumors including lung and pancreatic cancer.
Advertisement